Status:

COMPLETED

Phase 1 Safety, Pharmacokinetics And Pharmacodynamics Study Of Recombinant Factor VIIa Variant (813d) In Adult Subjects With Hemophilia

Lead Sponsor:

Catalyst Biosciences

Conditions:

Hemophilia A

Eligibility:

MALE

18-64 years

Phase:

PHASE1

Brief Summary

This study hypothesizes that the study drug, PF-05280602 (at the selected doses) will be safe to administer to subjects with severe Hemophilia A or B with or without inhibitors and will demonstrate ev...

Eligibility Criteria

Inclusion

  • Male subjects 18 to \<65 years old with severe hemophilia A or B with or without inhibitors to FVIII or FIX.
  • Subjects is willing and able to comply with the mandatory washout periods prior to screening and prior to dosing and through 48 hours post dosing. At screening this includes a washout of FIX for 96 hours and FVIII for 72 houts. At dosing this includes a washout of FIX for 96 hours and FVIII and other hemostatic agents for 72 hours through 48 hours post dosing.
  • Subjects must agree and commit to using a a highly effective method of birth control from the time of screening through four weeks after study drug administration.

Exclusion

  • Presence of a bleeding disorder in addition to hemophilia A or B.
  • Regular, concomitant therapy with immunomodulating drugs (eg, intravenous immunoglobulin, and routine systemic corticosteroids).
  • History of coronary artery disease, thrombolic disease or diagnosis of prothrombic disorder.

Key Trial Info

Start Date :

December 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

October 1 2015

Estimated Enrollment :

29 Patients enrolled

Trial Details

Trial ID

NCT01439971

Start Date

December 1 2011

End Date

October 1 2015

Last Update

May 12 2017

Active Locations (23)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 6 (23 locations)

1

University of California San Diego Medical Center

San Diego, California, United States, 92103-8651

2

New Haven Clinical Research Unit

New Haven, Connecticut, United States, 06511

3

Rush University Medical Center

Chicago, Illinois, United States, 60612

4

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio, United States, 45229